基本信息
views: 4
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Pedro José Alcolea Alcolea (January 23rd, 1980) is a Ph.D. in Biochemistry and Molecular Biology (June 25th, 2010), B.Sc. and M.Sc. in Biology (June 30th, 2010) from the Complutense University of Madrid, Graduate in Chemistry (October 9th, 2019) from the National University of Distance Education (UNED) and Professional Graduate in Music from the Amaniel Conservatory (June 26th, 2014). He received a pre-doctoral I3P (Spanish National Research Council, CSIC) and developed his post-doctoral research under the supervision of Prof. Peter J. Myler at the Center for Global Infectious Disease Research (formerly Seattle Biomedical Research Institute). In 2009, Dr. Alcolea passed public examinations consecutively obtaining two civil servant positions ascribed to the Spanish Ministry of Science and Innovation and is currently developing his scientific career as a Staff Scientist at the Margarita Salas Biological Research Center (CIBMS-CSIC).
Dr. Alcolea's 18-year long scientific career has been devoted to the search of vaccine candidates and therapeutic targets from Leishmania parasites by transcriptomics and proteomics including extracellular vesicles, characterization of these proteins, and vaccine development. Dr. Alcolea is the first author of a patent that was licensed in the EU (EP3297666), the USA (US 11,179,462 B2) and many other countries under the PCT. This patent protects a non-replicative antibiotic resistance-free mammalian expression plasmid vector called pPAL. The NeoLeish vaccine against canine leishmaniasis is based in the activated protein kinase C receptor analogue (LACK) and pPAL. This vaccine has successfully undergone evaluation by the European Medicines Agency (EMA) and is about to be available in the market.
Dr. Alcolea has coordinated five research projects as co-PI, has published 31 research articles in SCI-indexed journals (20 as the first author and 17 as the corresponding author), two book chapters, and 60 communications to national and international conferences. He has peer-reviewed 106 manuscripts submitted to scientific journals and is currently Editor of Frontiers in Microbiology (5,6), Editorial Board Topical Advisory Member of Microorganisms (IF 4,9) and guest editor of a special issue for Vaccines (IF 4,9). He has also been the supervisor of four doctoral thesis and two final degree projects, is currently supervising another Ph.D. thesis, taught 7 lessons in university masters, and carried out numerous science dissemination activities.
Research Interests
Papers共 43 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Frontiers in Immunology (2023): 1213193
International microbiology : the official journal of the Spanish Society for Microbiologyno. 1 (2022): 25-42
Pedro J Alcolea,Jaime Larraga,Daniel Rodríguez-Martín,Ana Alonso, Francisco J Loayza,José M Rojas,Silvia Ruiz-García,Andrés Louloudes-Lázaro, Ana B Carlón,Pedro J Sánchez-Cordón, Pablo Nogales-Altozano,Natalia Redondo,
Ana Alonso,Jaime Larraga, Francisco Javier Loayza,Enrique Martínez,Basilio Valladares,Vicente Larraga,Pedro José Alcolea
semanticscholar(2021)
Cited0Views0Bibtex
0
0
Load More
Author Statistics
#Papers: 43
#Citation: 683
H-Index: 15
G-Index: 25
Sociability: 5
Diversity: 0
Activity: 0
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn